Concepedia

Interleukin-6 in ANCA-associated vasculitis: Rationale for successful treatment with tocilizumab

Alvise Berti, Giulio Cavalli, Corrado Campochiaro, B. Guglielmi, Elena Baldissera, Stefano Cappio, Maria Grazia Sabbadini, Claudio Doglioni, Lorenzo Dagna

Seminars in Arthritis and Rheumatism · 2015 · 88 citations · 22 references

DOIFull text

Open access

Concepts

References

22

Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis

John H. Stone, Peter A. Merkel, Robert Spiera et al. · New England Journal of Medicine · 2010 · 2.7K citations · Full text

, , +17

Overview of the SF-36 Health Survey and the International Quality of Life Assessment (IQOLA) Project

John E. Ware, Barbara Gandek · Journal of Clinical Epidemiology · 1998 · 2.6K citations

, , +14

Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis

Rachel Jones, Jan Willem Cohen Tervaert, Thomas Häuser et al. · New England Journal of Medicine · 2010 · 1.7K citations · Full text

, , +14

Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies

Richard Watts, Suzanne Lane, Thomas Hanslik et al. · Annals of the Rheumatic Diseases · 2006 · 1.4K citations · Full text

, , +11

Etanercept plus Standard Therapy for Wegener's Granulomatosis

New England Journal of Medicine · 2005 · 836 citations · Full text

, , +6